These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

744 related items for PubMed ID: 24759080

  • 1. New management algorithms in multiple sclerosis.
    Sorensen PS.
    Curr Opin Neurol; 2014 Jun; 27(3):246-59. PubMed ID: 24759080
    [Abstract] [Full Text] [Related]

  • 2. An update on new and emerging therapies for relapsing-remitting multiple sclerosis.
    Weinstock-Guttman B.
    Am J Manag Care; 2013 Nov; 19(17 Suppl):s343-54. PubMed ID: 24494635
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Balancing the benefits and risks of disease-modifying therapy in patients with multiple sclerosis.
    Sørensen PS.
    J Neurol Sci; 2011 Dec; 311 Suppl 1():S29-34. PubMed ID: 22206763
    [Abstract] [Full Text] [Related]

  • 7. [Update on current care guidelines: multiple sclerosis].
    Duodecim; 2013 Dec; 129(5):548-9. PubMed ID: 23520898
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Update on disease-modifying treatments for multiple sclerosis.
    Carrithers MD.
    Clin Ther; 2014 Dec 01; 36(12):1938-1945. PubMed ID: 25218310
    [Abstract] [Full Text] [Related]

  • 15. Advances in and Algorithms for the Treatment of Relapsing-Remitting Multiple Sclerosis.
    Ingwersen J, Aktas O, Hartung HP.
    Neurotherapeutics; 2016 Jan 01; 13(1):47-57. PubMed ID: 26701666
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Emerging therapies in relapsing-remitting multiple sclerosis.
    Marriott JJ, O'Connor PW.
    Rev Recent Clin Trials; 2010 Sep 01; 5(3):179-88. PubMed ID: 20500147
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Treatment options for patients with multiple sclerosis who have a suboptimal response to interferon-β therapy.
    Freedman MS.
    Eur J Neurol; 2014 Mar 01; 21(3):377-87, e18-20. PubMed ID: 24237582
    [Abstract] [Full Text] [Related]

  • 20. Cost-effectiveness of fingolimod versus interferon beta-1a for relapsing remitting multiple sclerosis in the United States.
    Lee S, Baxter DC, Limone B, Roberts MS, Coleman CI.
    J Med Econ; 2012 Mar 01; 15(6):1088-96. PubMed ID: 22583065
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.